Display options
Cite
Lisco G, De Tullio A, Stragapede A, et al. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J Clin Med. 2021;10(13)doi: 10.3390/jcm10132920.
Lisco, G., De Tullio, A., Stragapede, A., Solimando, A. G., Albanese, F., Capobianco, M., Giagulli, V. A., Guastamacchia, E., De Pergola, G., Vacca, A., Racanelli, V., & Triggiani, V. (2021). COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. Journal of clinical medicine, 10(13), . https://doi.org/10.3390/jcm10132920
Lisco, Giuseppe, et al. "COVID-19 and the Endocrine System: A Comprehensive Review on the Theme." Journal of clinical medicine vol. 10,13 (2021). doi: https://doi.org/10.3390/jcm10132920
Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, Giagulli VA, Guastamacchia E, De Pergola G, Vacca A, Racanelli V, Triggiani V. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J Clin Med. 2021 Jun 29;10(13). doi: 10.3390/jcm10132920. PMID: 34209964; PMCID: PMC8269331.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2021 Jun 29;10(13). doi: 10.3390/jcm10132920.

COVID-19 and the Endocrine System: A Comprehensive Review on the Theme.

Journal of clinical medicine

Giuseppe Lisco, Anna De Tullio, Assunta Stragapede, Antonio Giovanni Solimando, Federica Albanese, Martina Capobianco, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Angelo Vacca, Vito Racanelli, Vincenzo Triggiani

Affiliations

  1. Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
  2. Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine "G. Baccelli", University of Bari School of Medicine, 70124 Bari, Italy.
  3. Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, 70124 Bari, Italy.
  4. National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.

PMID: 34209964 PMCID: PMC8269331 DOI: 10.3390/jcm10132920

Abstract

BACKGROUND AND AIM: The review aimed to summarize advances in the topic of endocrine diseases and coronavirus disease 2019 (COVID-19).

METHODS: Scientific and institutional websites and databases were searched and data were collected and organized, when plausible, to angle the discussion toward the following clinical issues. (1) Are patients with COVID-19 at higher risk of developing acute or late-onset endocrine diseases or dysfunction? (2) May the underlying endocrine diseases or dysfunctions be considered risk factors for poor prognosis once the infection has occurred? (3) Are there defined strategies to manage endocrine diseases despite pandemic-related constraints? Herein, the authors considered only relevant and more frequently observed endocrine diseases and disorders related to the hypothalamic-pituitary region, thyroid and parathyroid glands, calcium-phosphorus homeostasis and osteoporosis, adrenal glands, and gonads. Main. Data highlight the basis of some pathophysiological mechanisms and anatomical alterations of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-induced endocrine dysfunctions. Some conditions, such as adrenal insufficiency and cortisol excess, may be risk factors of worse clinical progression once the infection has occurred. These at-risk populations may require adequate education to avoid the SARS-CoV-2 infection and adequately manage medical therapy during the pandemic, even in emergencies. Endocrine disease management underwent a palpable restraint, especially procedures requiring obligate access to healthcare facilities for diagnostic and therapeutic purposes. Strategies of clinical triage to prioritize medical consultations, laboratory, instrumental evaluations, and digital telehealth solutions should be implemented to better deal with this probably long-term situation.

Keywords: Addison disease; COVID-19; Cushing syndrome; SARS-CoV-2; adrenal gland; hypercalcemia; osteoporosis; parathyroid; pituitary; review; thyroid; vitamin D

References

  1. Obes Res Clin Pract. 2020 Sep - Oct;14(5):398-403 - PubMed
  2. Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93 - PubMed
  3. J Thromb Haemost. 2020 Jun;18(6):1516-1517 - PubMed
  4. Immun Ageing. 2021 Jan 4;18(1):1 - PubMed
  5. J Clin Endocrinol Metab. 2015 Jun;100(6):2171-80 - PubMed
  6. Int J Mol Sci. 2018 Mar 15;19(3): - PubMed
  7. BMJ Case Rep. 2021 Jan 18;14(1): - PubMed
  8. Lancet Respir Med. 2020 Jul;8(7):687-695 - PubMed
  9. J Clin Invest. 2020 May 1;130(5):2620-2629 - PubMed
  10. Nature. 2020 Mar;579(7798):270-273 - PubMed
  11. Endocr Connect. 2018 Jul;7(7):G8-G11 - PubMed
  12. J Endocrinol Invest. 2020 Aug;43(8):1171-1172 - PubMed
  13. Growth Horm IGF Res. 2021 Feb;56:101363 - PubMed
  14. Eur Thyroid J. 2018 Aug;7(4):167-186 - PubMed
  15. J Endocrinol Invest. 2020 Dec;43(12):1819-1822 - PubMed
  16. N Engl J Med. 2021 Feb 25;384(8):693-704 - PubMed
  17. J Clin Endocrinol Metab. 2005 Mar;90(3):1897-9 - PubMed
  18. Endocrinology. 2008 Jun;149(6):3062-6 - PubMed
  19. N Engl J Med. 2020 Aug 6;383(6):590-592 - PubMed
  20. Lancet. 2020 Feb 22;395(10224):565-574 - PubMed
  21. P T. 2018 Feb;43(2):92-104 - PubMed
  22. Ther Adv Musculoskelet Dis. 2019 Oct 05;11:1759720X19877994 - PubMed
  23. BMC Med. 2020 Jul 15;18(1):220 - PubMed
  24. JAMA. 2003 Jun 4;289(21):2801-9 - PubMed
  25. Drugs R D. 2017 Mar;17(1):91-96 - PubMed
  26. Anaesthesiol Intensive Ther. 2019;51(3):205-209 - PubMed
  27. Rheumatology (Oxford). 2021 Jan 5;60(1):132-139 - PubMed
  28. J Endocrinol Invest. 2012 Dec;35(11):1021-9 - PubMed
  29. Sci Rep. 2016 Aug 03;6:30990 - PubMed
  30. Arch Endocrinol Metab. 2021 Mar 19;: - PubMed
  31. Lancet. 2021 Jan 9;397(10269):99-111 - PubMed
  32. J Med Virol. 2021 Mar;93(3):1361-1369 - PubMed
  33. Immunol Lett. 2005 Feb 15;97(1):107-13 - PubMed
  34. J Endocrinol Invest. 2021 Apr;44(4):765-771 - PubMed
  35. Bone. 2017 Dec;105:11-17 - PubMed
  36. Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-656 - PubMed
  37. J Clin Endocrinol Metab. 2020 Dec 1;105(12): - PubMed
  38. Med Hypotheses. 2020 Jul;140:109767 - PubMed
  39. Eur J Clin Invest. 2004 May;34(5):382-4 - PubMed
  40. J Clin Endocrinol Metab. 2020 Dec 1;105(12): - PubMed
  41. N Engl J Med. 2007 May 3;356(18):1809-22 - PubMed
  42. Eur J Endocrinol. 2021 May;184(5):637-645 - PubMed
  43. Respiration. 2021;100(2):116-126 - PubMed
  44. JAMA. 2020 Apr 28;323(16):1574-1581 - PubMed
  45. J Clin Endocrinol Metab. 2015 Feb;100(2):407-16 - PubMed
  46. Metabolism. 2020 Jul;108:154252 - PubMed
  47. Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105 - PubMed
  48. Diabetes Metab Syndr. 2021 Jan-Feb;15(1):337-342 - PubMed
  49. JAMA. 2020 Mar 17;323(11):1061-1069 - PubMed
  50. J Pharm Pharm Sci. 2020;23(1):75-85 - PubMed
  51. JAMA Netw Open. 2021 May 3;4(5):e2111398 - PubMed
  52. Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):22-37 - PubMed
  53. Endocrine. 2021 Jan;71(1):3-8 - PubMed
  54. Endocrine. 2020 May;68(2):251-252 - PubMed
  55. Folia Med (Plovdiv). 2020 Jun 30;62(2):223-229 - PubMed
  56. J Clin Endocrinol Metab. 2008 May;93(5):1526-40 - PubMed
  57. Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):e65-6 - PubMed
  58. Reprod Toxicol. 2006 Aug;22(2):234-41 - PubMed
  59. Res Rep Urol. 2020 Dec 01;12:615-621 - PubMed
  60. Eur J Endocrinol. 2009 Feb;160(2):233-7 - PubMed
  61. Compr Physiol. 2020 Sep 24;10(4):1277-1287 - PubMed
  62. Nat Med. 2020 Apr;26(4):450-452 - PubMed
  63. Metabolism. 2020 Jul;108:154262 - PubMed
  64. Lancet. 2020 Mar 28;395(10229):1054-1062 - PubMed
  65. Nat Rev Endocrinol. 2020 Sep;16(9):467-468 - PubMed
  66. J Clin Endocrinol Metab. 2008 Jun;93(6):2149-57 - PubMed
  67. Front Immunol. 2019 Aug 27;10:2028 - PubMed
  68. Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1140-4 - PubMed
  69. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2003-2006 - PubMed
  70. Eur J Endocrinol. 2017 Apr;176(4):471-480 - PubMed
  71. ANZ J Surg. 2020 Jun;90(6):963-964 - PubMed
  72. J Immunol. 2017 May 15;198(10):4046-4053 - PubMed
  73. Front Endocrinol (Lausanne). 2020 Sep 11;11:554 - PubMed
  74. Endocrinology. 2018 Sep 1;159(9):3306-3320 - PubMed
  75. J Med Virol. 2020 Apr;92(4):433-440 - PubMed
  76. Clin Endocrinol (Oxf). 1996 Feb;44(2):199-205 - PubMed
  77. Fertil Steril. 2020 Jun;113(6):1135-1139 - PubMed
  78. BMJ Case Rep. 2020 Aug 25;13(8): - PubMed
  79. J Med Virol. 2021 Feb;93(2):733-740 - PubMed
  80. Pituitary. 2020 Aug;23(4):327-337 - PubMed
  81. J Endocrinol Invest. 2020 Oct;43(10):1527-1528 - PubMed
  82. Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6485-90 - PubMed
  83. Endocrine. 2020 Aug;69(2):237-240 - PubMed
  84. Head Neck. 2020 Jun;42(6):1322-1324 - PubMed
  85. Clin Microbiol Infect. 2021 Jan;27(1):36-46 - PubMed
  86. Endocr Rev. 2019 Aug 1;40(4):1109-1151 - PubMed
  87. Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1429-1430 - PubMed
  88. J Endocrinol Invest. 2021 Mar;44(3):635-636 - PubMed
  89. Fertil Steril. 2020 Aug;114(2):233-238 - PubMed
  90. N Engl J Med. 2020 Jun 18;382(25):e100 - PubMed
  91. J Clin Endocrinol Metab. 2020 May 1;105(5): - PubMed
  92. J Endocrinol Invest. 2021 May;44(5):1085-1090 - PubMed
  93. Ann Endocrinol (Paris). 2021 Jun;82(3-4):210-213 - PubMed
  94. Am J Hematol. 2020 Jul;95(7):834-847 - PubMed
  95. J Clin Pathol. 2021 Apr;74(4):261-263 - PubMed
  96. Horm Behav. 2017 Feb;88:95-105 - PubMed
  97. Case Rep Endocrinol. 2020 Sep 28;2020:8891539 - PubMed
  98. J Interferon Cytokine Res. 2015 Oct;35(10):759-70 - PubMed
  99. Eur J Endocrinol. 2010 Mar;162(3):597-602 - PubMed
  100. Trials. 2020 Jun 26;21(1):573 - PubMed
  101. Crit Rev Immunol. 2012;32(1):23-63 - PubMed
  102. Andrology. 2021 Jan;9(1):53-64 - PubMed
  103. J Med Virol. 2021 Jan;93(1):456-462 - PubMed
  104. BMJ. 2020 Aug 25;370:m3223 - PubMed
  105. Endocrine. 2015 Feb;48(1):25-35 - PubMed
  106. Biochem Cell Biol. 2010 Aug;88(4):723-30 - PubMed
  107. J Hum Hypertens. 2021 Apr;35(4):304-307 - PubMed
  108. J Clin Endocrinol Metab. 2008 Apr;93(4):1351-8 - PubMed
  109. J Endocrinol Invest. 2020 Aug;43(8):1141-1147 - PubMed
  110. Nutrients. 2013 Jan 10;5(1):111-48 - PubMed
  111. JBMR Plus. 2020 Aug 22;: - PubMed
  112. Endocr Metab Immune Disord Drug Targets. 2021;21(1):91-110 - PubMed
  113. J Bone Miner Res. 2020 Jun;35(6):1009-1013 - PubMed
  114. JAMA. 2020 Oct 6;324(13):1330-1341 - PubMed
  115. BMC Infect Dis. 2021 Feb 22;21(1):200 - PubMed
  116. Drug Metab Dispos. 2007 Sep;35(9):1687-93 - PubMed
  117. J Clin Orthop Trauma. 2020 Jul;11(Suppl 4):S431-S441 - PubMed
  118. Endocrinology. 2017 Oct 1;158(10):3676-3683 - PubMed
  119. Nutrients. 2020 Jul 15;12(7): - PubMed
  120. Urol Int. 2020;104(9-10):678-683 - PubMed
  121. J Med Virol. 2021 Apr;93(4):2021-2028 - PubMed
  122. N Engl J Med. 2020 Oct 29;383(18):1757-1766 - PubMed
  123. Arch Pathol Lab Med. 2020 Oct 1;144(10):1159-1160 - PubMed
  124. Med Hypotheses. 2004;63(5):855-62 - PubMed
  125. Head Neck. 2020 Jun;42(6):1325-1328 - PubMed
  126. Int J Mol Sci. 2018 Sep 08;19(9): - PubMed
  127. Thyroid. 2021 Jan;31(1):8-11 - PubMed
  128. J Immunol. 2001 Nov 1;167(9):4974-80 - PubMed
  129. Br J Anaesth. 2019 May;122(5):e73-e75 - PubMed
  130. Nutrients. 2018 Apr 27;10(5): - PubMed
  131. Neuroendocrinology. 2010;92 Suppl 1:50-4 - PubMed
  132. Climacteric. 2016 Aug;19(4):329-36 - PubMed
  133. J Clin Endocrinol Metab. 2020 Oct 1;105(10): - PubMed
  134. Int J Mol Sci. 2017 Sep 12;18(9): - PubMed
  135. Eur J Endocrinol. 2018 May;178(5):447-458 - PubMed
  136. J Clin Endocrinol Metab. 2007 Jul;92(7):2415-20 - PubMed
  137. N Engl J Med. 2007 Jul 19;357(3):266-81 - PubMed
  138. Ann Nucl Med. 2011 Dec;25(10):749-54 - PubMed
  139. N Engl J Med. 2021 May 13;384(19):1866-1868 - PubMed
  140. J Endocrinol Invest. 2018 Jul;41(7):849-876 - PubMed
  141. Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29 - PubMed
  142. Pituitary. 2018 Dec;21(6):631-641 - PubMed
  143. Clin Endocrinol (Oxf). 2005 Aug;63(2):197-202 - PubMed
  144. Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509 - PubMed
  145. Crit Care. 2013 Jun 04;17(3):R106 - PubMed
  146. Hum Reprod. 2021 Jun 18;36(7):2063-2064 - PubMed
  147. Nat Rev Immunol. 2016 Oct;16(10):626-38 - PubMed
  148. PLoS One. 2019 Sep 24;14(9):e0222313 - PubMed
  149. J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:2324709621999954 - PubMed
  150. Hormones (Athens). 2014 Jul-Sep;13(3):420-3 - PubMed
  151. Diabetes Obes Metab. 2016 Dec;18(12):1274-1278 - PubMed
  152. Eur J Endocrinol. 2020 Jul;183(1):G33-G39 - PubMed
  153. J Endocrinol Invest. 2020 Aug;43(8):1169-1170 - PubMed
  154. Clin Exp Immunol. 2019 Jan;195(1):52-63 - PubMed
  155. Endocrinol Metab Clin North Am. 2010 Jun;39(2):365-79, table of contents - PubMed
  156. Endocrine. 2020 Jun;68(3):475-478 - PubMed
  157. N Engl J Med. 2021 Feb 4;384(5):403-416 - PubMed
  158. J Clin Endocrinol Metab. 2020 Feb 1;105(2): - PubMed
  159. Eur J Endocrinol. 2016 Aug;175(2):G1-G34 - PubMed
  160. Med Drug Discov. 2020 Jun;6:100041 - PubMed
  161. Lipids Health Dis. 2018 Oct 12;17(1):234 - PubMed
  162. Endocr Metab Immune Disord Drug Targets. 2020;20(5):646-653 - PubMed
  163. Endocrine. 2020 Nov;70(2):218-231 - PubMed
  164. Eur J Endocrinol. 2020 Jul;183(1):G1-G7 - PubMed
  165. Sci Rep. 2014 Nov 24;4:7176 - PubMed
  166. J Endocrinol Invest. 2021 Jun;44(6):1335-1336 - PubMed
  167. Med Hypotheses. 2020 Nov;144:110167 - PubMed
  168. JAMA Cardiol. 2020 Jul 1;5(7):802-810 - PubMed
  169. J Pharmacol Pharmacother. 2012 Apr;3(2):118-26 - PubMed
  170. Lancet Diabetes Endocrinol. 2021 Apr;9(4):197-199 - PubMed
  171. Auto Immun Highlights. 2020 Oct 6;11(1):15 - PubMed
  172. Int J Environ Res Public Health. 2020 Sep 11;17(18): - PubMed
  173. Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028 - PubMed
  174. Endocrine. 2020 Jun;68(3):485-488 - PubMed
  175. Eur J Endocrinol. 2020 Jul;183(1):G9-G15 - PubMed
  176. Virology. 2018 Apr;517:3-8 - PubMed
  177. Nat Med. 2020 Oct;26(10):1531-1533 - PubMed
  178. Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792 - PubMed
  179. J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622 - PubMed
  180. J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744 - PubMed
  181. J Clin Endocrinol Metab. 2008 Mar;93(3):674-6 - PubMed
  182. Adv Exp Med Biol. 2018;1067:239-253 - PubMed
  183. Immunol Lett. 2020 Sep;225:31-32 - PubMed
  184. Neuroendocrinology. 2010;92 Suppl 1:96-101 - PubMed
  185. Nat Microbiol. 2020 Apr;5(4):536-544 - PubMed
  186. BMJ. 2020 Sep 1;370:m3320 - PubMed
  187. JAMA. 2020 May 12;323(18):1775-1776 - PubMed
  188. Nat Rev Immunol. 2020 Jul;20(7):442-447 - PubMed
  189. Hormones (Athens). 2021 Mar;20(1):219-221 - PubMed
  190. Hum Reprod. 2021 May 17;36(6):1520-1529 - PubMed
  191. J Clin Endocrinol Metab. 2020 Jul 1;105(7): - PubMed
  192. J Visc Surg. 2020 Jun;157(3S1):S43-S49 - PubMed
  193. World J Mens Health. 2021 Jul;39(3):489-495 - PubMed
  194. BMJ Open. 2021 Feb 25;11(2):e045524 - PubMed
  195. Med Hypotheses. 2020 Dec;145:110329 - PubMed
  196. Andrology. 2021 Jan;9(1):99-106 - PubMed
  197. Mayo Clin Proc. 2020 Aug;95(8):1710-1714 - PubMed
  198. Endocrinology. 2020 Sep 1;161(9): - PubMed
  199. J Endocrinol Invest. 2021 Feb;44(2):387-388 - PubMed
  200. JAMA. 2021 Apr 6;325(13):1318-1320 - PubMed
  201. Vaccine. 2021 Jan 22;39(4):667-677 - PubMed
  202. Inflamm Regen. 2020 Feb 7;40:2 - PubMed
  203. Lancet. 2020 Feb 15;395(10223):473-475 - PubMed
  204. J Endocrinol Invest. 2020 Aug;43(8):1173-1174 - PubMed
  205. J Endocrinol Invest. 2021 Mar 25;: - PubMed
  206. J Endocrinol Invest. 2020 Jul;43(7):1027-1031 - PubMed
  207. J Am Coll Nutr. 2021 Feb;40(2):104-110 - PubMed
  208. Eur J Endocrinol. 2019 Apr;180(4):P23-P54 - PubMed
  209. Ann Intern Med. 2020 Oct 6;173(7):516-526 - PubMed
  210. Aging Male. 2020 Dec;23(5):1493-1503 - PubMed
  211. Biol Reprod. 2020 Jun 23;103(1):4-6 - PubMed
  212. Neuroendocrinology. 2010;92 Suppl 1:55-9 - PubMed
  213. Obesity (Silver Spring). 2020 Jul;28(7):1195-1199 - PubMed
  214. Eur J Endocrinol. 2020 Jul;183(1):G17-G23 - PubMed
  215. Endocr Metab Immune Disord Drug Targets. 2021 Jan 01;: - PubMed
  216. J Clin Endocrinol Metab. 2013 Jun;98(6):2277-84 - PubMed
  217. Rev Endocr Metab Disord. 2020 Nov 25;: - PubMed
  218. J Endocrinol Invest. 2021 May;44(5):1031-1040 - PubMed
  219. J Med Virol. 2021 Feb;93(2):820-830 - PubMed
  220. Front Endocrinol (Lausanne). 2020 Aug 18;11:565 - PubMed
  221. J Biol Chem. 2010 Dec 10;285(50):38751-5 - PubMed
  222. Horm Behav. 2012 Aug;62(3):263-71 - PubMed
  223. Med Mal Infect. 2020 Jun;50(4):382-383 - PubMed
  224. Endocrine. 2021 Feb;71(2):273-280 - PubMed
  225. Lancet Respir Med. 2020 Dec;8(12):1159 - PubMed
  226. Singapore Med J. 2020 Jul 16;: - PubMed
  227. Eur J Endocrinol. 2020 Aug;183(2):G57-G65 - PubMed
  228. Andrology. 2021 Jan;9(1):88-98 - PubMed
  229. Metabolism. 2019 Mar;92:193-205 - PubMed
  230. BMC Med. 2020 Nov 25;18(1):369 - PubMed
  231. Endocrine. 2020 Apr;68(1):2-5 - PubMed
  232. J Endocrinol Invest. 2021 Feb 13;: - PubMed
  233. Pituitary. 2021 Apr;24(2):143-145 - PubMed
  234. Endocr Connect. 2016 Sep;5(5):G9-G11 - PubMed
  235. J Med Case Rep. 2020 Aug 24;14(1):134 - PubMed
  236. J Investig Med. 2011 Aug;59(6):881-6 - PubMed
  237. Nat Rev Immunol. 2008 Sep;8(9):737-44 - PubMed
  238. J Clin Endocrinol Metab. 2012 Jun;97(6):2039-49 - PubMed
  239. JAMA Netw Open. 2020 May 1;3(5):e208292 - PubMed
  240. Nutrients. 2020 Apr 02;12(4): - PubMed
  241. Lancet. 2020 Mar 28;395(10229):1033-1034 - PubMed
  242. BMJ. 2021 Feb 18;372:n494 - PubMed
  243. Clin Endocrinol (Oxf). 2021 Apr 4;: - PubMed
  244. J Med Virol. 2020 Apr;92(4):448-454 - PubMed
  245. Eur J Endocrinol. 2020 Oct;183(4):381-387 - PubMed
  246. Trends Endocrinol Metab. 2020 Sep;31(9):655-669 - PubMed
  247. Endocrine. 2021 Apr;72(1):12-19 - PubMed
  248. Thyroid. 2001 Oct;11(10):929-34 - PubMed
  249. Cell. 2020 Apr 16;181(2):271-280.e8 - PubMed
  250. Front Physiol. 2021 Apr 14;12:651408 - PubMed
  251. Sci Rep. 2021 Feb 12;11(1):3735 - PubMed
  252. J Nucl Med. 2020 Sep;61(9):1278-1283 - PubMed
  253. Endocr Relat Cancer. 2020 Nov;27(11):R407-R416 - PubMed
  254. BMJ. 2017 Feb 15;356:i6583 - PubMed
  255. Eur J Endocrinol. 2020 Jul;183(1):G25-G32 - PubMed
  256. Endocr Rev. 2005 Aug;26(5):704-28 - PubMed
  257. Endocr Connect. 2016 Sep;5(5):G7-G8 - PubMed
  258. Aging (Albany NY). 2020 Jun 25;12(12):11287-11295 - PubMed
  259. Front Med (Lausanne). 2021 Jan 07;7:590805 - PubMed
  260. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346 - PubMed
  261. J Endocrinol Invest. 2020 Jul;43(7):1035-1036 - PubMed
  262. Lancet Diabetes Endocrinol. 2020 Jul;8(7):570 - PubMed
  263. N Engl J Med. 2001 Sep 13;345(11):841 - PubMed
  264. BMJ Open. 2021 Jan 11;11(1):e044640 - PubMed
  265. ISRN Endocrinol. 2014 Jan 22;2014:105456 - PubMed
  266. N Engl J Med. 2020 Dec 31;383(27):2603-2615 - PubMed
  267. Ann Endocrinol (Paris). 2020 Oct;81(5):507-510 - PubMed
  268. Endocrine. 2020 Dec;70(3):441-453 - PubMed
  269. Front Immunol. 2015 Mar 18;6:100 - PubMed
  270. J Clin Endocrinol Metab. 2006 Dec;91(12):4849-53 - PubMed
  271. Med Hypotheses. 2020 Jul;140:109785 - PubMed
  272. Cochrane Database Syst Rev. 2021 Mar 11;3:CD013879 - PubMed
  273. J Clin Med Res. 2020 Oct;12(10):634-639 - PubMed
  274. Life Sci Alliance. 2020 Jul 23;3(9): - PubMed
  275. Nature. 2020 Mar;579(7798):265-269 - PubMed
  276. Nature. 2020 Jul;583(7816):437-440 - PubMed
  277. Osteoporos Int. 2016 Aug;27(8):2395-410 - PubMed
  278. Hematol Oncol Stem Cell Ther. 2020 Jul 30;: - PubMed

Publication Types